JAMES MCNALLY: Open Payments
NPI 1568423895 · JENNINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 30 payments from 13 companies in 2025. Trend: 2023 $1,404 · 2024 $842 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 6 | $196 |
| Ardelyx, Inc. | 3 | $158 |
| Boston Scientific Corporation | 1 | $138 |
| Gilead Sciences, Inc. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Lilly USA, LLC | 3 | $53 |
| ABBVIE INC. | 2 | $46 |
| Exact Sciences Corporation | 2 | $46 |
| PFIZER INC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: SUBLOCADE, IBSRELA, Intracept, CAPLYTA, MOUNJARO, QULIPTA, The Cologuard Plus Collection Kit, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
